| Literature DB >> 33936200 |
Shunjun Wang1,2, HuSai Ma2, Huayang Li1,3, Quan Liu1,3, Suiqing Huang1, Lin Huang1,3, Li Luo1,3, Yupeng Jiang4, Zhongkai Wu1,3.
Abstract
Globally, non-small cell lung cancer (NSCLC) is the most fatal form of malignancy. Numerous studies have shown that people living at high altitudes are at a higher risk for cancer. Hypoxia is one of the most important features in high altitude area. Compared with normal cells, cancer cells are more adapted to hypoxia atmosphere. However, at high altitudes, hypoxic conditions are also accompanied by other altered environmental conditions. To identify the single influence of hypoxia, we performed second-generation sequencing to identify gene expression changes triggered by the different oxygen concentrations. We identified 782 genes in A549 cells and 1122 genes in H520 cells that showed altered expression by the combined analysis in 5% oxygen concentration group and 1% oxygen concentration group control group. We further analyzed these targets and found 113 genes altered in both cell lines. Interestingly, we found KxD1 was the only one in both top 10 lists. Further analysis revealed KxD1 to be significantly elevated in NSCLC patients and negatively correlated with prognosis in stage I and II NSCLC patients. Moreover, this correlation reversed in stage III patients. Additionally, compared with patients who only received clean margin operation or chemotherapy, patients who received radiotherapy also showed opposite result. Thus, KxD1 may be a promising target for the treatment of NSCLC in high-altitude areas.Entities:
Year: 2021 PMID: 33936200 PMCID: PMC8055392 DOI: 10.1155/2021/5558304
Source DB: PubMed Journal: J Oncol ISSN: 1687-8450 Impact factor: 4.375
Figure 1Hypoxia promotes metastasis and invasion of NSCLC. (a) Cellular wound healing assays of tumor cells (100x), N 21% O2, L 5% O2, S 1% O2; the results of wound healing assays. (b) Cell invasion was measured by Transwell assays (100x). The numbers of invading cells was counted from five fields of view in each group. (c) The mRNA level of VEGFR, FN1, and GLUT1 was detected by qRT-PCR.ns. P > 0.05, P < 0.05, P < 0.01, and P < 0.001.
Figure 2The results of NSCLC RNA-seq. (a) Heat map of correlation between samples. (b) Analysis and statistics of gene and Transcription expression difference. The horizontal axis is the name of difference comparison, and the vertical axis is the number of up-down difference genes. Among them, the green is downregulated counts and the red is upregulated counts. (c) Heatmaps of differential expressed genes (DEGs) and differential expressed transcripts (DETs) in NSCLC cells under different oxygen concentrations. On the left is the tree diagram of gene clustering. (d) Transcripts volcano maps of H520 and A549 cells compared with 21% O2VS 5% O2 and 21% O2VS 1% O2.
Figure 3Functional enrichment and KEGG analysis of DETS. (a) Venn diagram of differential transcripts. (b) Scatter plot of top 20 enriched GO terms of molecular function (MF), biological process (BP), and cellular component (CC) separately. (c) Scatter plot of top 30 enriched KEGG pathways.
Figure 4KXD1 is the most valuable protein according to DETs analysis. (a)Venn diagram of the most significant difference transcripts between H520 and A549. (b) PPI networks among the target genes of 113. (c) Venn diagram of top 10 DETs in A549 and H520 induced by hypoxia (N/L, 21% O2/5% O2; N/S, 21% O2/1% O2).
Figure 5KXD1 was overexpressed both in LUSC and LUAD. (a) IHC stained tissues representing KXD1 expression is shown in NSCLC or normal lung tissues, respectively. (b) Expression level of KXD1 in normal lung tissue and NSCLC tissue.
Figure 6Survival analysis of KxD1. (a) Survival analysis of KxD1 in the NSCLC population. (b) Survival analysis of KxD1 in different stages of the NSCLC population. (c) Survival analysis of KxD1 in NSCLC patients treated with different treatments.